JP2020521755A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2020521755A5 JP2020521755A5 JP2019565179A JP2019565179A JP2020521755A5 JP 2020521755 A5 JP2020521755 A5 JP 2020521755A5 JP 2019565179 A JP2019565179 A JP 2019565179A JP 2019565179 A JP2019565179 A JP 2019565179A JP 2020521755 A5 JP2020521755 A5 JP 2020521755A5
- Authority
- JP
- Japan
- Prior art keywords
- item
- injectable composition
- items
- composition
- composition according
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims description 88
- 239000007972 injectable composition Substances 0.000 claims description 83
- 210000004204 blood vessel Anatomy 0.000 claims description 57
- CBPNZQVSJQDFBE-FUXHJELOSA-N Temsirolimus Chemical compound C1C[C@@H](OC(=O)C(C)(CO)CO)[C@H](OC)C[C@@H]1C[C@@H](C)[C@H]1OC(=O)[C@@H]2CCCCN2C(=O)C(=O)[C@](O)(O2)[C@H](C)CC[C@H]2C[C@H](OC)/C(C)=C/C=C/C=C/[C@@H](C)C[C@@H](C)C(=O)[C@H](OC)[C@H](O)/C(C)=C/[C@@H](C)C(=O)C1 CBPNZQVSJQDFBE-FUXHJELOSA-N 0.000 claims description 44
- 229960000235 temsirolimus Drugs 0.000 claims description 44
- QFJCIRLUMZQUOT-UHFFFAOYSA-N temsirolimus Natural products C1CC(O)C(OC)CC1CC(C)C1OC(=O)C2CCCCN2C(=O)C(=O)C(O)(O2)C(C)CCC2CC(OC)C(C)=CC=CC=CC(C)CC(C)C(=O)C(OC)C(O)C(C)=CC(C)C(=O)C1 QFJCIRLUMZQUOT-UHFFFAOYSA-N 0.000 claims description 44
- 239000007924 injection Substances 0.000 claims description 43
- 238000002347 injection Methods 0.000 claims description 43
- 229960003957 dexamethasone Drugs 0.000 claims description 28
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 claims description 28
- 210000001367 artery Anatomy 0.000 claims description 22
- 210000003127 knee Anatomy 0.000 claims description 19
- 150000003839 salts Chemical class 0.000 claims description 19
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 13
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 claims description 9
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 6
- 210000004351 coronary vessel Anatomy 0.000 claims description 6
- 239000011627 DL-alpha-tocopherol Substances 0.000 claims description 3
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 claims description 3
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 3
- 229960004543 anhydrous citric acid Drugs 0.000 claims description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 3
- 229940068918 polyethylene glycol 400 Drugs 0.000 claims description 3
- 239000000244 polyoxyethylene sorbitan monooleate Substances 0.000 claims description 3
- 235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 claims description 3
- 229920000053 polysorbate 80 Polymers 0.000 claims description 3
- 229940068968 polysorbate 80 Drugs 0.000 claims description 3
- 229960004063 propylene glycol Drugs 0.000 claims description 3
- 239000008354 sodium chloride injection Substances 0.000 claims description 3
- 229960000984 tocofersolan Drugs 0.000 claims description 3
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 claims description 3
- 238000000034 method Methods 0.000 description 89
- 239000008194 pharmaceutical composition Substances 0.000 description 36
- 230000032823 cell division Effects 0.000 description 32
- 239000003112 inhibitor Substances 0.000 description 32
- 239000003862 glucocorticoid Substances 0.000 description 14
- 208000019553 vascular disease Diseases 0.000 description 14
- 208000037803 restenosis Diseases 0.000 description 12
- 230000002093 peripheral effect Effects 0.000 description 10
- 239000002872 contrast media Substances 0.000 description 5
- 210000005166 vasculature Anatomy 0.000 description 5
- 208000005764 Peripheral Arterial Disease Diseases 0.000 description 4
- 208000030831 Peripheral arterial occlusive disease Diseases 0.000 description 4
- 210000001519 tissue Anatomy 0.000 description 4
- 206010002383 Angina Pectoris Diseases 0.000 description 2
- 206010059245 Angiopathy Diseases 0.000 description 2
- 201000001320 Atherosclerosis Diseases 0.000 description 2
- 206010007559 Cardiac failure congestive Diseases 0.000 description 2
- 206010019280 Heart failures Diseases 0.000 description 2
- 206010028851 Necrosis Diseases 0.000 description 2
- 229930012538 Paclitaxel Natural products 0.000 description 2
- 206010060872 Transplant failure Diseases 0.000 description 2
- 230000006907 apoptotic process Effects 0.000 description 2
- 206010003119 arrhythmia Diseases 0.000 description 2
- 230000006793 arrhythmia Effects 0.000 description 2
- 210000001627 cerebral artery Anatomy 0.000 description 2
- 210000002808 connective tissue Anatomy 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 230000000302 ischemic effect Effects 0.000 description 2
- 208000030175 lameness Diseases 0.000 description 2
- 210000002414 leg Anatomy 0.000 description 2
- 208000010125 myocardial infarction Diseases 0.000 description 2
- 230000017074 necrotic cell death Effects 0.000 description 2
- 229960001592 paclitaxel Drugs 0.000 description 2
- 210000001147 pulmonary artery Anatomy 0.000 description 2
- 210000002254 renal artery Anatomy 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- RCINICONZNJXQF-MZXODVADSA-N taxol Chemical compound O([C@@H]1[C@@]2(C[C@@H](C(C)=C(C2(C)C)[C@H](C([C@]2(C)[C@@H](O)C[C@H]3OC[C@]3([C@H]21)OC(C)=O)=O)OC(=O)C)OC(=O)[C@H](O)[C@@H](NC(=O)C=1C=CC=CC=1)C=1C=CC=CC=1)O)C(=O)C1=CC=CC=C1 RCINICONZNJXQF-MZXODVADSA-N 0.000 description 2
- 230000002792 vascular Effects 0.000 description 2
- 210000003462 vein Anatomy 0.000 description 2
- 241001125046 Sardina pilchardus Species 0.000 description 1
- 229940123237 Taxane Drugs 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000019512 sardine Nutrition 0.000 description 1
- 229940037128 systemic glucocorticoids Drugs 0.000 description 1
- DKPFODGZWDEEBT-QFIAKTPHSA-N taxane Chemical class C([C@]1(C)CCC[C@@H](C)[C@H]1C1)C[C@H]2[C@H](C)CC[C@@H]1C2(C)C DKPFODGZWDEEBT-QFIAKTPHSA-N 0.000 description 1
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201762511797P | 2017-05-26 | 2017-05-26 | |
| US62/511,797 | 2017-05-26 | ||
| US201862624528P | 2018-01-31 | 2018-01-31 | |
| US62/624,528 | 2018-01-31 | ||
| PCT/US2018/034713 WO2018218182A1 (en) | 2017-05-26 | 2018-05-25 | Combination therapy for treatment of restenosis |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2020521755A JP2020521755A (ja) | 2020-07-27 |
| JP2020521755A5 true JP2020521755A5 (enExample) | 2021-07-26 |
| JP7137584B2 JP7137584B2 (ja) | 2022-09-14 |
Family
ID=64397143
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019565179A Active JP7137584B2 (ja) | 2017-05-26 | 2018-05-25 | 再狭窄の処置のための併用療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (4) | US10576063B2 (enExample) |
| EP (1) | EP3629774A4 (enExample) |
| JP (1) | JP7137584B2 (enExample) |
| KR (1) | KR20200008166A (enExample) |
| CN (1) | CN110996687A (enExample) |
| AU (1) | AU2018272061A1 (enExample) |
| CA (1) | CA3064780A1 (enExample) |
| WO (1) | WO2018218182A1 (enExample) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US11541015B2 (en) | 2017-05-17 | 2023-01-03 | Massachusetts Institute Of Technology | Self-righting systems, methods, and related components |
| IL301683B2 (en) | 2017-05-17 | 2025-02-01 | Massachusetts Inst Technology | Self-healing systems and related components and methods |
| AU2018272061A1 (en) | 2017-05-26 | 2020-01-02 | Mercator Medsystems, Inc. | Combination therapy for treatment of restenosis |
| US11654267B2 (en) | 2018-03-14 | 2023-05-23 | Mercator Medsystems, Inc. | Medical instrument and medical method for localized drug delivery |
| EP3793667A1 (en) | 2018-05-17 | 2021-03-24 | Massachusetts Institute of Technology | Systems for electrical stimulation |
| US11497552B2 (en) | 2019-07-09 | 2022-11-15 | Juad, Inc. | Apparatus, systems and methods for transvascular access to the brain |
| AU2020410545A1 (en) * | 2019-12-19 | 2022-08-11 | Triviumvet Dac | Veterinary formulations comprising rapamycin and methods of using the same for treating animal diseases |
| MX2023009197A (es) | 2021-03-11 | 2023-08-21 | Alpha Tau Medical Ltd | Aplicador de radioterapia. |
| MX2023015500A (es) | 2021-06-30 | 2024-01-22 | Alpha Tau Medical Ltd | Aplicador de radioterapia con dispensacion perpendicular o radial en angulo. |
Family Cites Families (84)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US1044174A (en) | 1912-03-18 | 1912-11-12 | Orville Bray | Elevator automatic safety appliance. |
| HU212760B (en) | 1989-06-20 | 1997-02-28 | Denes | Method and device for the apportion of chemical materials into the vein wall |
| US5527532A (en) | 1989-11-13 | 1996-06-18 | President And Fellows Of Harvard College | Extraluminal regulation of the growth and repair of tubular structures in vivo |
| US5196024A (en) | 1990-07-03 | 1993-03-23 | Cedars-Sinai Medical Center | Balloon catheter with cutting edge |
| US5270047A (en) | 1991-11-21 | 1993-12-14 | Kauffman Raymond F | Local delivery of dipyridamole for the treatment of proliferative diseases |
| US5538504A (en) | 1992-07-14 | 1996-07-23 | Scimed Life Systems, Inc. | Intra-extravascular drug delivery catheter and method |
| DE4235506A1 (de) | 1992-10-21 | 1994-04-28 | Bavaria Med Tech | Katheter zur Injektion von Arzneimitteln |
| EP0689465A1 (en) | 1993-03-18 | 1996-01-03 | Cedars-Sinai Medical Center | Drug incorporating and releasing polymeric coating for bioprosthesis |
| US5362718A (en) * | 1994-04-18 | 1994-11-08 | American Home Products Corporation | Rapamycin hydroxyesters |
| US6009877A (en) | 1994-06-24 | 2000-01-04 | Edwards; Stuart D. | Method for treating a sphincter |
| US5722989A (en) | 1995-05-22 | 1998-03-03 | The Regents Of The University Of California | Microminiaturized minimally invasive intravascular micro-mechanical systems powered and controlled via fiber-optic cable |
| US5645564A (en) | 1995-05-22 | 1997-07-08 | Regents Of The University Of California | Microfabricated therapeutic actuator mechanisms |
| US5746716A (en) | 1995-07-10 | 1998-05-05 | Interventional Technologies Inc. | Catheter for injecting fluid medication into an arterial wall |
| US5693029A (en) | 1995-07-10 | 1997-12-02 | World Medical Manufacturing Corporation | Pro-cell intra-cavity therapeutic agent delivery device |
| US20020001581A1 (en) | 1996-03-04 | 2002-01-03 | Lynch Carmel M. | Methods for transducing cells in blood vessels using recombinant AAV vectors |
| AU737078C (en) | 1996-05-24 | 2002-05-02 | Angiotech Pharmaceuticals, Inc. | Compositions and methods for treating or preventing diseases of body passageways |
| US5911737A (en) | 1997-02-28 | 1999-06-15 | The Regents Of The University Of California | Microfabricated therapeutic actuators |
| US5866561A (en) | 1997-08-21 | 1999-02-02 | Scimed Life Systems, Inc. | Local delivery of estrogen for angiogenesis |
| US20040067197A1 (en) | 1997-11-26 | 2004-04-08 | Guy Leclerc | Radiolabeled DNA carrier, method of preparation and therapeutic uses thereof |
| US6059766A (en) | 1998-02-27 | 2000-05-09 | Micro Therapeutics, Inc. | Gynecologic embolotherapy methods |
| US8029561B1 (en) * | 2000-05-12 | 2011-10-04 | Cordis Corporation | Drug combination useful for prevention of restenosis |
| US6503231B1 (en) | 1998-06-10 | 2003-01-07 | Georgia Tech Research Corporation | Microneedle device for transport of molecules across tissue |
| US6210392B1 (en) | 1999-01-15 | 2001-04-03 | Interventional Technologies, Inc. | Method for treating a wall of a blood vessel |
| US7094765B1 (en) | 1999-01-29 | 2006-08-22 | Avi Biopharma, Inc. | Antisense restenosis composition and method |
| US6302870B1 (en) | 1999-04-29 | 2001-10-16 | Precision Vascular Systems, Inc. | Apparatus for injecting fluids into the walls of blood vessels, body cavities, and the like |
| US6494862B1 (en) | 1999-07-13 | 2002-12-17 | Advanced Cardiovascular Systems, Inc. | Substance delivery apparatus and a method of delivering a therapeutic substance to an anatomical passageway |
| US6283947B1 (en) | 1999-07-13 | 2001-09-04 | Advanced Cardiovascular Systems, Inc. | Local drug delivery injection catheter |
| DE60008001T2 (de) | 1999-09-21 | 2004-09-02 | Institut De Cardiologie De Montreal, Montreal | Lokale verabreichung von 17-beta estradiol zur verbesserung der vaskularen endothelialen funktion nach gefässverletzungen |
| US6864355B1 (en) | 2000-05-02 | 2005-03-08 | Yale University | Inhibition of NF-κB activation by blockade of IKKβ-NEMO interactions at the NEMO binding domain |
| US20160287708A9 (en) | 2000-03-15 | 2016-10-06 | Orbusneich Medical, Inc. | Progenitor Endothelial Cell Capturing with a Drug Eluting Implantable Medical Device |
| US7300662B2 (en) | 2000-05-12 | 2007-11-27 | Cordis Corporation | Drug/drug delivery systems for the prevention and treatment of vascular disease |
| US6602241B2 (en) | 2001-01-17 | 2003-08-05 | Transvascular, Inc. | Methods and apparatus for acute or chronic delivery of substances or apparatus to extravascular treatment sites |
| US6625486B2 (en) | 2001-04-11 | 2003-09-23 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for intracellular delivery of an agent |
| US20020188310A1 (en) | 2001-06-08 | 2002-12-12 | Seward Kirk Partick | Microfabricated surgical device |
| US6547303B1 (en) | 2001-08-13 | 2003-04-15 | Johnson Controls Technology Company | Pivoting seating system |
| US6547803B2 (en) | 2001-09-20 | 2003-04-15 | The Regents Of The University Of California | Microfabricated surgical device for interventional procedures |
| US6860867B2 (en) | 2001-09-20 | 2005-03-01 | The Regents Of The University Of California | Method of interventional surgery |
| DE60235775D1 (de) | 2001-11-08 | 2010-05-06 | Ziscoat N V | Intraluminale Vorrichtung mit einer therapeutisches-mittel enthaltenden Beschichtung |
| US7247149B2 (en) | 2001-12-20 | 2007-07-24 | Advanced Cardiovascular Systems, Inc. | Contact and penetration depth sensor for a needle assembly |
| BR0306858A (pt) | 2002-01-10 | 2004-11-03 | Novartis Ag | Sistemas de liberação de drogas para a prevenção e tratamento de doenças vasculares compreendendo rapamicina e derivados da mesma |
| US7744584B2 (en) | 2002-01-22 | 2010-06-29 | Mercator Medsystems, Inc. | Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation |
| AU2003205315A1 (en) | 2002-01-22 | 2003-09-02 | Endobionics, Inc. | Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia |
| US10441747B2 (en) | 2002-01-22 | 2019-10-15 | Mercator Medsystems, Inc. | Methods and systems for inhibiting vascular inflammation |
| US20060189941A1 (en) * | 2002-01-22 | 2006-08-24 | Mercator Medsystems, Inc. | Methods and kits for volumetric distribution of pharmaceutical agents via the vascular adventitia and microcirculation |
| US20070078620A1 (en) | 2002-02-13 | 2007-04-05 | Mercator Medsystems Inc. | Methods and kits for delivering pharmaceutical agents into the coronary vascular adventitia |
| US8574195B2 (en) | 2002-06-10 | 2013-11-05 | Advanced Cardiovascular Systems, Inc. | Systems and methods for detecting tissue contact and needle penetration depth using static fluid pressure measurements |
| AU2003256499A1 (en) | 2002-07-11 | 2004-02-02 | Setagon, Inc. | Expandable body having deployable microstructures and related methods |
| CA2493878C (en) | 2002-07-30 | 2013-07-23 | Wyeth | Parenteral formulations containing a rapamycin hydroxyester |
| US7008411B1 (en) | 2002-09-30 | 2006-03-07 | Advanced Cardiovascular Systems, Inc. | Method and apparatus for treating vulnerable plaque |
| US20040162542A1 (en) | 2002-12-03 | 2004-08-19 | Endobionics, Inc. | Methods and systems for treating the vasculature with estrogens |
| WO2004082491A1 (en) | 2003-03-18 | 2004-09-30 | Robert Ganz | Method and device for delivering a substance to tissue layers |
| US20050163711A1 (en) | 2003-06-13 | 2005-07-28 | Becton, Dickinson And Company, Inc. | Intra-dermal delivery of biologically active agents |
| US20050182071A1 (en) | 2003-09-16 | 2005-08-18 | Endobionics, Inc. | Methods and systems for inhibiting arrhythmia |
| US20050232965A1 (en) | 2004-04-15 | 2005-10-20 | Robert Falotico | Local administration of a combination of rapamycin and 17 beta-estradiol for the treatment of vulnerable plaque |
| WO2005112569A2 (en) | 2004-05-13 | 2005-12-01 | Medtronic Vascular, Inc. | Methods for compounding and delivering a therapeutic agent to the adventitia of a vessel |
| JP2005349202A (ja) | 2004-06-08 | 2005-12-22 | Cordis Corp | 治療薬を組織内へ導入する器具および方法 |
| CN100435755C (zh) | 2004-07-27 | 2008-11-26 | 微创医疗器械(上海)有限公司 | 药物洗脱支架 |
| US20080038316A1 (en) * | 2004-10-01 | 2008-02-14 | Wong Vernon G | Conveniently implantable sustained release drug compositions |
| EP2927693A1 (en) | 2004-10-06 | 2015-10-07 | The Brigham and Women's Hospital | Relevance of achieved levels of markers of systemic inflammation following treatment |
| WO2007120897A2 (en) | 2006-04-13 | 2007-10-25 | The Trustees Of Columbia University In The City Of New York | Compositions and intraluminal devices for inhibiting vascular stenosis |
| US20070269385A1 (en) | 2006-05-18 | 2007-11-22 | Mercator Medsystems, Inc | Devices, methods, and systems for delivering therapeutic agents for the treatment of sinusitis, rhinitis, and other disorders |
| US7691080B2 (en) | 2006-09-21 | 2010-04-06 | Mercator Medsystems, Inc. | Dual modulus balloon for interventional procedures |
| US8092822B2 (en) | 2008-09-29 | 2012-01-10 | Abbott Cardiovascular Systems Inc. | Coatings including dexamethasone derivatives and analogs and olimus drugs |
| US20100092534A1 (en) | 2008-10-10 | 2010-04-15 | Medtronic Vascular, Inc. | Combination Local Delivery Using a Stent |
| US20100233266A1 (en) | 2009-03-13 | 2010-09-16 | Cleek Robert L | Articles and methods of treating vascular conditions |
| JP2010260857A (ja) | 2009-04-10 | 2010-11-18 | Santen Pharmaceut Co Ltd | シロリムス誘導体を有効成分として含有する網脈絡膜疾患の治療剤 |
| JP2010269857A (ja) | 2009-05-19 | 2010-12-02 | Canon Inc | シート給送装置及び該装置を備えた画像形成装置 |
| US8911766B2 (en) | 2009-06-26 | 2014-12-16 | Abbott Cardiovascular Systems Inc. | Drug delivery compositions including nanoshells for triggered drug release |
| KR101970342B1 (ko) | 2011-04-28 | 2019-04-18 | 아브락시스 바이오사이언스, 엘엘씨 | 나노입자 조성물의 혈관내 전달 및 그의 용도 |
| US20120302954A1 (en) | 2011-05-25 | 2012-11-29 | Zhao Jonathon Z | Expandable devices coated with a paclitaxel composition |
| US9220716B2 (en) * | 2011-07-26 | 2015-12-29 | Children's Medical Center Corporation | Methods and compositions for the treatment of proliferative vascular disorders |
| US20130035665A1 (en) | 2011-08-05 | 2013-02-07 | W. L. Gore & Associates, Inc. | Polymer-Based Occlusion Devices, Systems and Methods |
| US9220759B2 (en) | 2012-02-23 | 2015-12-29 | Abbott Cardiovascular Systems Inc. | Treatment of diabetic patients with a drug eluting stent and adjunctive therapy |
| CN103284948A (zh) | 2012-02-29 | 2013-09-11 | 单颖 | 负载西罗莫司类化合物或其衍生物的聚合物组合物的制备及应用 |
| US20130303496A1 (en) | 2012-05-08 | 2013-11-14 | Abbott Cardiovascular Systems Inc. | Method Of Treating Vascular Lesions |
| WO2014118696A2 (en) | 2013-01-29 | 2014-08-07 | Gland Pharma Limited | Pharmacuetical compositions of rapamycin esters and its derivatives |
| WO2015081821A1 (zh) | 2013-12-02 | 2015-06-11 | 北京键凯科技有限公司 | 聚乙二醇-多爪寡肽键合的雷帕霉素衍生物 |
| WO2016123051A1 (en) | 2015-01-26 | 2016-08-04 | Mercator Medsystems, Inc. | Methods and systems for inhibiting vascular inflammation |
| KR101892908B1 (ko) * | 2015-11-02 | 2018-08-29 | 아주대학교산학협력단 | 글루코코르티코이드계 화합물을 포함하는 비소세포성 폐암 치료용 약학 조성물 |
| WO2017078405A1 (ko) | 2015-11-02 | 2017-05-11 | 아주대학교산학협력단 | 글루코코르티코이드계 화합물을 포함하는 폐암 치료용 약학 조성물 |
| KR102123715B1 (ko) | 2016-08-16 | 2020-06-16 | 주식회사 엘지화학 | 고체 산화물 연료전지 |
| WO2018057788A1 (en) | 2016-09-22 | 2018-03-29 | Mercator Medsystems, Inc. | Treatment of restenosis using temsirolimus |
| AU2018272061A1 (en) | 2017-05-26 | 2020-01-02 | Mercator Medsystems, Inc. | Combination therapy for treatment of restenosis |
| AU2021352423A1 (en) | 2020-10-01 | 2023-06-08 | Mercator Medsystems, Inc. | Perivascular anti-inflammatory therapy for venous thrombosis |
-
2018
- 2018-05-25 AU AU2018272061A patent/AU2018272061A1/en not_active Abandoned
- 2018-05-25 KR KR1020197038156A patent/KR20200008166A/ko not_active Ceased
- 2018-05-25 CN CN201880049930.2A patent/CN110996687A/zh active Pending
- 2018-05-25 CA CA3064780A patent/CA3064780A1/en active Pending
- 2018-05-25 JP JP2019565179A patent/JP7137584B2/ja active Active
- 2018-05-25 US US15/990,167 patent/US10576063B2/en active Active
- 2018-05-25 WO PCT/US2018/034713 patent/WO2018218182A1/en not_active Ceased
- 2018-05-25 EP EP18806949.6A patent/EP3629774A4/en not_active Withdrawn
-
2019
- 2019-10-02 US US16/591,467 patent/US10925863B2/en active Active
-
2021
- 2021-01-14 US US17/149,631 patent/US11813249B2/en active Active
-
2023
- 2023-10-04 US US18/481,110 patent/US20240024296A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2020521755A5 (enExample) | ||
| Heiss et al. | Reocclusion prophylaxis with dipyridamole combined with acetylsalicylic acid following PTA | |
| AU2012214396B2 (en) | Methods for treating pulmonary hypertension | |
| AU2010277725B2 (en) | Otamixaban for treatment of elderly and renal impaired non-ST elevation myocardial infarction patients | |
| KR20190072011A (ko) | 나토키나제와 항염증제를 유효성분으로 포함하는 혈소판 응집 억제용 또는 혈전용해용 의약 조성물 | |
| ES2904256T3 (es) | Métodos para tratar, reducir la incidencia de y/o prevenir eventos isquémicos | |
| Wilmer | Intracoronary high-dose bolus tirofiban administration during complex coronary interventions: A United States-based case series | |
| Rubin et al. | An embolizing lesion in a minimally diseased aorta | |
| US9597322B2 (en) | Otamixaban for use in the treatment of non-ST elevation acute coronary syndrome in patients planned to undergo coronary artery bypass grafting | |
| JP2532918B2 (ja) | グアニジノ安息香酸誘導体を有効成分として含有する抗動脈硬化剤 | |
| US20250195549A1 (en) | New use | |
| JPWO2013103148A1 (ja) | 側副血行路発達促進剤 | |
| Erden et al. | A case of acute stent thrombosis treated successfully with intracoronary tirofiban | |
| JP5589838B2 (ja) | 血管性疾患の予防剤及び／又は治療剤 | |
| Kojodjojo et al. | Clearing Disseminated Venous Thromboembolism in a Single Procedure Using Thrombolytic-Free Large Bore Suction Thrombectomy: A Versatile Toolbox to Unclog the Venous Circulation | |
| Wizemann et al. | Biphasic action of prostacyclin on intraocular pressure | |
| EA019424B1 (ru) | Медицинское применение 3-(2,2,2-триметилгидразиниум)пропионат гидрофумарата и дигидрофосфата | |
| WO2025133022A1 (en) | Fractalkine receptor antagonists for use in the prevention of thrombus formation and/or growth | |
| EP4593833A1 (en) | Fractalkine receptor antagonists for use in the prevention of thrombus formation and/or growth | |
| Truong et al. | Recurrent intraoperative coronary artery spasm in a patient with coronary artery aneurysm | |
| Ványi et al. | Metoprolol reduces ‘compensatory’coronary blood flow following occlusion of an adjacent branch without altering post-occlusion hyperaemia | |
| van den Ouweland et al. | Abstracts of papers clinical pharmacological meeting | |
| Rigatelli et al. | Medical Therapy for Critical Limb Ischemia | |
| JPWO2011065444A1 (ja) | 抗血栓剤 | |
| Vet—QC09CA02 | Eprosartan Mesilate (BANM, rINNM) |